Concurrent Group III

ISSCR 2018 Plenary and Concurrent

2 - USING STEM CELLS FOR DRUG DISCOVERY IN NEUROSCIENCE

6/22/2018
13:20 - 13:45

Ricardo Dolmetsch

Novartis Institutes for BioMedical Research, Inc., MA, United States

Dr. Ricardo Dolmetsch is Global Head of Neuroscience at the Novartis Institutes for BioMedical Research. His group is responsible for developing medicines to treat neuropsychiatric, neurodevelopmental and neurodegenerative diseases. The group is focused on targets and mechanisms that have been validated in humans either by human genetic studies or by astute clinical observations. The department is a world leader in developing preclinical models of disease using human induced pluripotent stem cells and has also developed novel methods for studying the function of circuits in the brain.
Ricardo joined Novartis from Stanford University where he was a Professor in the school of medicine.
Ricardo received his undergraduate degree from Brown University, his graduate degree from Stanford University and was a postdoctoral fellow at Harvard University.

Presentation(s):

Send Email for Ricardo Dolmetsch


Assets

2 - USING STEM CELLS FOR DRUG DISCOVERY IN NEUROSCIENCE



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for USING STEM CELLS FOR DRUG DISCOVERY IN NEUROSCIENCE